Neuropsychopharmacology advance online publication 9 May 2007
Blockade of brain -opioid receptor (-OR) and -opioid receptor (-OR) was investigated in recently abstinent alcohol-dependent subjects (N=21) maintained on naltrexone.
The FDA recommended therapeutic dose of naltrexone was sufficient to produce near complete inhibition of the -OR in recently abstinent alcohol dependent subjects.
The lower percent inhibition of -OR and greater variability in -OR blockade by naltrexone across subjects may contribute to individual differences in treatment outcomes to naltrexone.
Further investigations on the relationship between individual differences in -OR blockade by naltrexone and clinical outcomes should be explored.
Reprint Request E-mail: eweerts@jhmi.edu
_____________________________________________________________